Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.45), $0.48 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $225 million versus the consensus estimate of $152.34 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.